Subscribe To Our Free Newsletter |
Biocon Limited – Press Release
Biocon Limited has informed the Exchange about press release dated 17-Oct-2022 titled "Biocon Biologics Out-Licenses Two Biosimilar Assets to Yoshindo for Commercialization in Japan"......